QuantWave's forecast for NIKE, INC. proved to be highly accurate as the stock price hit the predicted target with a significant 16.82% profit margin....
QuantWave, an automated forecasting platform, recently achieved a significant milestone with its price target forecast for NIKE, INC. The forecast signal was issued on May 28, 2025, with a price of $61....
On June 5, 2025, QuantWave issued a forecast signal for NIKE, INC. (NYSE: NKE) with a price target of $71.67, predicting a long position. The stock was trading at $62.35 at the time of the signal....
NIKE, INC.'s stock recently achieved a significant milestone by hitting the price target forecasted by QuantWave's automated forecasting platform....
NIKE, INC.'s stock has successfully reached the price target forecasted by QuantWave, resulting in a profitable outcome for investors....
QuantWave, the automated forecasting platform, recently saw one of its price target forecasts for NIKE, INC. come to fruition with a significant 20.9% profit....
On May 20, 2025, QuantWave issued a forecast signal for NIKE, INC. with a predicted long direction when the stock was trading at 61.83 $. Fast forward to June 27, 2025, and the target price of 71....
On June 9, 2025, QuantWave's forecast signal for NIKE, INC. indicated a long position at a price of 61.59 $. Fast forward to June 27, 2025, the stock reached the predicted target price of 71....
On June 6, 2025, QuantWave issued a forecast signal for NIKE, INC., predicting a long position with a price target of $71.67. The stock was trading at $62.48 at the time of the signal....
QuantWave, the automated forecasting platform, successfully predicted a long position for NIKE, INC. with a forecast signal date of 2025-05-23 at a price of 59.32 $....
QuantWave, the automated forecasting platform, successfully predicted a price target for the stock of NIKE, INC. The forecast signal was initiated on May 16, 2025, with the stock trading at 62.37 USD....
QuantWave, the automated forecasting platform, recently celebrated a significant achievement as the stock of NIKE, INC. successfully hit the price target forecast with a profit margin of 20.49%....
In a successful prediction by QuantWave, the stock of NIKE, INC. has reached the forecasted price target, resulting in a profit of 18.43% for investors....
On June 17, 2025, QuantWave, the automated forecasting platform, issued a long signal for NIKE, INC. stock when it was trading at 59.69 $....
NIKE, INC. has seen a significant achievement as the stock reached the forecast price target set by QuantWave with an impressive profit margin of 21.06%....
On June 16, 2025, QuantWave, the automated forecasting platform, issued a long signal for NIKE, INC. stock when it was trading at $61.58....
On June 26, 2025, QuantWave issued a forecast signal for NIKE, INC., predicting a long position with the stock trading at 62.22 $....
On June 24, 2025, QuantWave, an automated forecasting platform, issued a long signal for NIKE, INC. stock when it was trading at $61.1....
On June 13, 2025, QuantWave issued a long signal for NIKE, INC. stock when it was trading at 60.22 $. The platform accurately predicted the stock's movement, and on June 27, 2025, the target price of 71....
On April 25, 2025, QuantWave's automated forecasting platform issued a long signal for The Goldman Sachs Group, Inc. (GS) at a price of 539.27 $....
On April 24, 2025, QuantWave, the automated forecasting platform, issued a long signal for THE GOLDMAN SACHS GROUP, INC. (GS) when the stock was trading at $539.78....
On April 28, 2025, QuantWave's forecast for The Goldman Sachs Group, Inc. (GS) indicated a long position with a price of $540.8....
QuantWave, the automated forecasting platform, has successfully reached its price target forecast for The Goldman Sachs Group, Inc. stock, resulting in a profit of 27.06%....
Micron Technology Inc. recently announced its financial results for the third quarter of fiscal 2025, reporting record revenue of $9.3 billion....
AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....